270 related articles for article (PubMed ID: 30427714)
1. Long-Term Survival and Glycemic Control with Toceranib Phosphate and Prednisone for a Metastatic Canine Insulinoma.
Flesner BK; Fletcher JM; Smithee T; Boudreaux B
J Am Anim Hosp Assoc; 2019; 55(1):e55105. PubMed ID: 30427714
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report.
Fuertes-Recuero M; Vázquez-Fernández E; Lizasoain-Sánz G; Arroba-Alonso A; Sánchez-López A; Martínez-de-Merlo E; Suárez-Redondo M; Ortiz-Diez G
Vet Res Commun; 2024 Jun; 48(3):1921-1927. PubMed ID: 38453822
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of palliative therapy, alone or in combination with toceranib phosphate, in dogs diagnosed with metastatic or recurrent beta-cell neoplasia.
Alonso-Miguel D; García-San José P; González Sanz S; Clarés Moral I; Pérez-Alenza MD
N Z Vet J; 2021 Jul; 69(4):234-239. PubMed ID: 33944682
[TBL] [Abstract][Full Text] [Related]
4. Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990-1997).
Tobin RL; Nelson RW; Lucroy MD; Wooldridge JD; Feldman EC
J Am Vet Med Assoc; 1999 Jul; 215(2):226-30. PubMed ID: 10416477
[TBL] [Abstract][Full Text] [Related]
5. Use of a bipolar vessel-sealing device in resection of canine insulinoma.
Wouters EG; Buishand FO; Kik M; Kirpensteijn J
J Small Anim Pract; 2011 Mar; 52(3):139-45. PubMed ID: 21338362
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival in an aged Labrador retriever with a metastatic insulinoma.
Rychel J; Worley DR; Hardy CS; Webb BT
J Am Anim Hosp Assoc; 2013; 49(3):224-9. PubMed ID: 23325593
[TBL] [Abstract][Full Text] [Related]
7. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma.
Musser ML; Johannes CM
BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in a retrospective cohort of 28 dogs with insulinoma.
Polton GA; White RN; Brearley MJ; Eastwood JM
J Small Anim Pract; 2007 Mar; 48(3):151-6. PubMed ID: 17355606
[TBL] [Abstract][Full Text] [Related]
9. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Resection of a Pancreatic β Cell Tumor in a Dog.
Mcclaran JK; Pavia P; Fischetti AJ; Donovan TA
J Am Anim Hosp Assoc; 2017; 53(6):338-345. PubMed ID: 28892425
[TBL] [Abstract][Full Text] [Related]
11. Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.
Carlsten KS; London CA; Haney S; Burnett R; Avery AC; Thamm DH
J Vet Intern Med; 2012; 26(1):135-41. PubMed ID: 22176473
[TBL] [Abstract][Full Text] [Related]
12. A retrospective evaluation of 51 dogs with insulinoma.
Trifonidou MA; Kirpensteijn J; Robben JH
Vet Q; 1998; 20 Suppl 1():S114-5. PubMed ID: 9652051
[No Abstract] [Full Text] [Related]
13. Diazoxide treatment of canine insulinoma.
Parker AJ; Musselman EM; O'Brien D
Vet Rec; 1981 Aug; 109(9):178-9. PubMed ID: 6275601
[No Abstract] [Full Text] [Related]
14. Insulin-secreting tumor: diagnosis and medical and surgical management in 55 dogs.
Leifer CE; Peterson ME; Matus RE
J Am Vet Med Assoc; 1986 Jan; 188(1):60-4. PubMed ID: 3003016
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
[TBL] [Abstract][Full Text] [Related]
16. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.
Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH
J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008
[TBL] [Abstract][Full Text] [Related]
17. Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia.
Pérez ML; Culver S; Owen JL; Dunbar M; Kow K; Breen M; Milner RJ
Anticancer Drugs; 2013 Nov; 24(10):1098-103. PubMed ID: 23995854
[TBL] [Abstract][Full Text] [Related]
18. Toceranib phosphate in the treatment of canine thyroid carcinoma: 42 cases (2009-2018).
Sheppard-Olivares S; Bello NM; Wood E; Szivek A; Biller B; Hocker S; Wouda RM
Vet Comp Oncol; 2020 Dec; 18(4):519-527. PubMed ID: 32012432
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided caudal thoracic paravertebral block in a dog with an insulinoma undergoing partial pancreatectomy.
Quesada N; Sanchis-Mora S; Medina-Serra R
Vet Anaesth Analg; 2021 Jul; 48(4):632-633. PubMed ID: 34083138
[No Abstract] [Full Text] [Related]
20. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).
Musser ML; Taikowski KL; Johannes CM; Bergman PJ
BMC Vet Res; 2018 Sep; 14(1):272. PubMed ID: 30176869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
